HalliwellB., GutteridgeJ.M.C., CrossC.E.Free radicals, antioxidants, and human disease: where are we now?J Lab Clin Med1992; 119: 598–620.
2.
KnightJ.A.Diseases related to oxygen-derived free radicals. Ann Clin Lab Sci1995; 25: 111–21.
3.
RoselaarS.E., NazhatN.B., WinyardP.G., JonesP., CunninghamJ., BlakeD.R.Detection of oxidants in uremic plasma by electron spin resonance spectroscopy. Kidney Int1995; 48: 199–206.
4.
WesthuyzenJ., AdamsC.E., FlemingS.J.Evidence for oxidative stress during in vitro dialysis. Nephron1995; 70: 49–54.
5.
HimmelfarbJ., LazarusJ.M., HakimR.Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis1991; 17: 271–6.
6.
HimmelfarbJ., AultK.A., HolbrookD., LeeberD.A., HakimR.M.Intradialytic granulocyte reactive oxygen species production: a prospective, crossover trial. J Am Soc Nephrol1993; 4: 178–86.
7.
EpperleinM.M., Nourooz-ZadehJ., JayasenaS.D., HothersallJ.S., Noronha-DutraA., NeildG.H.Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol1998; 9: 457–63.
8.
RichardM.J., ArnaudJ., JurkovitzC.Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron1991; 57: 10–5.
HaklarG., YegenagaI., YalcinA.S.Evaluation of oxidant stress in chronic hemodialysis patients: use of different parameters. Clin Chim Acta1995; 234: 109–14.
11.
JacksonP., LoughreyC.M., LightbodyJ.H., McNameeP.T., YoungI.S.Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem1995; 41: 1135–8.
12.
DaschnerM., LenhartzH., BötticherD.Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int1996; 50: 1268–72.
13.
AntosM., Jeren-StrujicB., RaosV., RomicZ., MatanovicB.Evidence of antioxidant role of vitamin C in chronic hemodialysis patients. Trace Elem Electrolytes1997; 14: 159–61.
14.
KoenigJ.S., FischerM., BulantE., TiranB., ElmadfaI., DrumlW.Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wien Klin Wochenschr1997; 109: 13–9.
15.
GiardiniO., Taccone-GallucciM., LubranoR.Effects of alpha-tocopherol administration on red blood cell membrane lipid peroxidation in hemodialysis patients. Clin Nephrol1984; 21: 174–7.
16.
GiardiniO., Taccone-GallucciM., LubranoR.Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. Nephron1984; 36: 235–7.
17.
NenovD., PaskalevD., YankovaT., TchankovaP.Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rhEPO treatment. Int Artif Organs1995; 19: 436–9.
18.
Taccone-GallucciM., LubranoR., Del PrincipeD.Platelet lipid peroxidation in haemodialysis patients: effects of vitamin E supplementation. Nephrol Dial Transplant1989; 4: 975–8.
19.
EsterbauerH., SchaurR.J., ZollnerH.Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med1991; 11: 81–128.
20.
GotohM., NagaseS., AoyagiK.Thiobarbituric acid reactive substances are increased in the subcutaneous fat tissue of patients with end-stage renal disease. Nephrol Dial Transplant1997; 12: 713–7.
21.
Taccone-GallucciM., LubranoR., BelliA.Lack of oxidative damage in serum polyunsaturated fatty acids before and after dialysis in chronic uremic patients. Int J Artif Organs1989; 12: 515–8.
Delmas-BeauvieuxM-C, CombeC., PeuchantE.Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron. Nephron1995; 69: 404–10.
24.
HultqvistM., HegbrantJ., Nilsson-ThorellC.Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin Nephrol1997; 47: 37–46.
25.
BiasioliS., SchiavonR., De FantiE., CavalcantiG., GiavarinaD.The role of erythrocytes in the deperoxidative processes in people on hemodialysis. ASAIO J1996; 42: M890–4.
26.
Witko-SarsatV., FriedlanderM., Capeillère-BlandinC.Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int1996; 49: 1304–13.
NagaseS., AoyagiK., HirayamaA.Decreased serum antioxidant activity of hemodialysis patients demonstrated by methylguanidine synthesis and microsomal lipid peroxidation. Nephron1996; 74: 555–60.
29.
DasguptaA., MalhotraD., LevyH., MarcadisD., BlackwellW., JohnstonD.Decreased total antioxidant capacity but normal lipid hydroperoxide concentrations in sera of critically ill patients. Life Sci1997; 60: 335–40.
30.
NagaseS., AoyagiK., HirayamaA.Favorable effect of hemodialysis on decreased serum antioxidant activity in hemodialysis patients demonstrated by electron spin resonance. J Am Soc Nephrol1997; 8: 1157–63.
FreiB., EnglandL., AmesB.N.Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA1989; 86: 6377–81.
40.
OnoK.Effects of large dose vitamin E supplementation on anemia in hemodialysis patients. Nephron1985; 40: 440–5.
41.
PastorM.C., SierraC., BonalJ., TeixidóJ.Serum and erythrocyte tocopherol in uremic patients: effect of hemodialysis versus peritoneal dialysis. Am J Nephrol1993; 13: 238–43.
42.
HaT.K.K., SattarN., TalwarD.Abnormal antioxidant vitamin and carotenoid status in chronic renal failure. Q J Med1996; 89: 765–9.
43.
ZimaT., JanebováM., NemecekK., BártováV.Retinol and α-tocopherol in hemodialysis patients. Ren Fail1998; 20: 505–12.
44.
PeuchantE., CarbonneauM-A, DubourgL.Lipoperoxidation in plasma and red blood cells of patients undergoing hemodialysis: vitamins A, E, and iron status. Free Radic Biol Med16; 339–46.
45.
TrioloL., LippaS., OradeiA., De SoleP., MoriR.Serum coenzyme Q1O in uremic patients on chronic hemodialysis. Nephron1994; 66: 153–6.
46.
PanzettaO., CominaciniL., GarbinU.Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration. Clin Nephrol1995; 44: 303–9.
47.
SteinG., SperschneiderH., KoppeS.Vitamin levels in chronic renal failure and need for supplementation. Blood Purif1985; 3: 52–62.
48.
MiyataT., WadaY., CaiZ.Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int1997; 51: 1170–81.
49.
SullivanJ.F., EisensteinA.B.Ascorbic acid depletion in patients undergoing chronic hemodialysis. Am J Clin Nutr1970; 23: 1339–46.
50.
SullivanJ.F., EisensteinA.B., MottolaO.M., MittalA.K.The effect of dialysis on plasma and tissue levels of vitamin C. Trans Am Soc Artif Intern Organs1972; 18: 277–82.
51.
WashkoP.W., WelchR.W., DhariwalK.R., WangY., LevineM.Ascorbic acid and dehydroascorbic acid analyses in biological samples. Anal Biochem1992; 204: 1–14.
52.
RoseR.C.Transport of ascorbic acid and other water-soluble vitamins. Biochim Biophys Acta1988; 947: 335–66.
53.
HercbergS., PreziosiP., GalanP.Vitamin status of a healthy French population: dietary intake and biochemical markers. Int J Vitam Nutr Res1994; 64: 220–32.
54.
HallfrischJ., MullerD.C., SinghV.N.Vitamin A and E intakes and plasma concentrations of retinol, ß-carotene, and α-tocopherol in men and women of the Baltimore Longitudinal Study of Aging. Am J Clin Nutr1994; 60: 176–82.
55.
BeckerB.N., HimmelfarbJ., HenrichW.L., HakimR.M.Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol1997; 8: 476–86.
56.
GalleJ., WannerC.Oxidative stress and vascular injury - relevant for atherogenesis in uraemic patients?Nephrol Dial Transplant1997; 12: 2480–3.
57.
GivertzM.M., ColucciW.S.New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet1998; 352(suppl. I): S34–8.
58.
MakoffR.Water-soluble vitamin status in patients with renal disease treated with hemodialysis or peritoneal dialysis. J Ren Nutr1991; 1: 56–73.
59.
MakoffR.Vitamin supplementation in patients with renal disease. Dial Transplant1992; 21: 18–24+36.
60.
DescombesE., HanckA.B., FellayG.Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int1993; 43: 1319–28.
61.
DevineW.Review of nutritional status and diet in dialysis and renal transplant patients. Dial Transplant1994; 23: 38–41+47–8.
62.
PruC., EatonJ., KjellstrandC.Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. Nephron1985; 39: 112–6.
63.
WolfsonM.Use of water-soluble vitamins in patients with chronic renal failure. Semin Dial1988: 1: 28–32.
64.
OnoK.Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients. Clin Nephrol1986; 26: 239–43.
65.
OnoK.The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients. Clin Nephrol1989; 31: 31–4.
66.
MaianiG., AzziniE., Ferro-LuzziA.Vitamin C. Int J Vitam Nutr Res1993; 63: 289–95.
67.
YalcinA.S., YurtkuranM., DilekK., KilincA., TagaY., EmerkK.The effect of vitamin E therapy on plasma and erythrocyte lipid peroxidation in chronic hemodialysis patients. Clin Chim Acta1989; 185: 109–12.
68.
GilmourE.R., HartleyG.H., GoodshipT.H.J.Trace elements and vitamins in renal disease. In: MitchW.E., KlahrS., eds. Nutrition and the kidney.2nd ed.Boston: Little, Brown and Company, 1993; 114–31.
69.
BuoncristianiU., GalliF., RovidatiS., AlbertiniM.C., CampusG., CanestrariF.Oxidative damage during hemodialysis using a vitamin E-modified dialysis membrane: a preliminary characterization. Nephron1997; 77: 57–61.
70.
GalliF., RovidatiS., ChiarantiniL., CampusG., CanestrariF., BuoncristianiU.Bioreactivity and biocompatibility of a vitamin E-modified multilayer hemodialysis filter. Kidney Int1998; 54: 580–9.
